ENMAJU
Live / Allowed — Notice of allowance issued (as of 06 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 19 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99345009
- Mark type
- Stylized text
- Filed
- 19 Aug 2025
- Published for opposition
- 11 Nov 2025
- Attorney of record
- Danielle Rivera
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders
Owner
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
Prosecution history
- 06 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Nov 2025 — PUBLISHED FOR OPPOSITION
- 05 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Oct 2025 — ASSIGNED TO EXAMINER
- 19 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 19 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 19 Aug 2025 — NEW APPLICATION ENTERED